Creative Medical Technology Holdings, Inc. is a clinical-stage biotechnology company focused on treating erectile dysfunction and stroke using stem cell treatments. The company focuses on regenerative medical solutions for unmet Urological and Neurological needs. Through researchers and collaborations with leading academic institutions, Creative Medical Technology has acquired a groundbreaking stem cell (Amniostem), developed complete treatment offerings for erectile dysfunction, launched a 40-patient trial for ED at UCLA and are breaking new ground for treating stroke using its newly acquired amniotic fluid-based stem cell.